Tesamorelin

Name: Tesamorelin
Brand: Quantum Labs
SKU: tesamorelin
Price: 169.00 AUD
Availability: OutOfStock

Stabilised GHRH analogue

Tesamorelin GHRH analogue research peptide, Australian-shipped. Lab-verified ≥99% purity.

4.8 (52)

Dose

10mg / vial

Form

Lyophilised powder

Research Use Only. This compound is sold strictly for in-vitro research and laboratory purposes and is not intended for human consumption or therapeutic use. By purchasing you confirm you are a qualified researcher and agree to our full disclaimer.

Get notified when back in stock

We'll email you as soon as this compound is restocked. No spam, one-off notification only.

🧪Lab Verified

✓3rd Party Tested

⚡Fast Worldwide Shipping

🔒Secure Crypto Payment

Overview

Stabilised growth hormone releasing hormone analogue studied for effects on visceral adipose tissue and IGF-1 axis activity in research models.

Tesamorelin is a stabilised analogue of growth-hormone-releasing hormone (GHRH) — modified to extend its half-life relative to native GHRH. It is one of the most studied GHRH-analogue research peptides and the only one of its class to have undergone regulatory approval in any jurisdiction (for HIV-associated lipodystrophy, in the US, under the brand name Egrifta). Quantum Labs supplies Tesamorelin as a lyophilised powder for Australian research applications.

Research on Tesamorelin has covered models of growth-hormone secretion, body composition, lipid metabolism, and IGF-1 dynamics. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.

Research Mechanism

Studied for selective binding to the GHRH receptor with extended half-life. Research associated with reduced visceral fat markers and elevated IGF-1 in study populations.

Lab Report

HPLC verified against a ≥99% purity specification. Independently tested by accredited third-party laboratories.

In Quantum Labs protocols

Hormonal Support Protocol12w

Check compatibility with other compounds →

Stacks Well With

Researcher FAQ

Tesamorelin — frequently asked questions

What is Tesamorelin?

Tesamorelin is a stabilised synthetic analogue of growth-hormone-releasing hormone (GHRH). It is studied in growth-hormone research and pre-clinical models of metabolic regulation and body composition.

Is Tesamorelin legal in Australia?

Tesamorelin is not approved as a therapeutic in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies Tesamorelin for research use only.

What is the difference between Tesamorelin and CJC-1295?

Both are GHRH-analogue research peptides. CJC-1295 has a longer half-life and a stronger ability to extend the duration of GH pulses; Tesamorelin's modifications produce a shorter-acting but well-characterised GHRH-mimicking profile. They are studied as parallel research tools for different aspects of GHRH-pathway signalling.

What is the typical Tesamorelin research dosage?

Published clinical research (in the US, for the approved indication) has used 2 mg daily subcutaneous Tesamorelin. Research-protocol dosing varies by model. Human therapeutic dosing is not established in Australia.